J&J sells breast care unit to Devicor
This article was originally published in The Gray Sheet
Executive Summary
Johnson & Johnson's Ethicon Endo-Surgery unit completes the divestiture of its breast care business to Devicor Medical Products on July 12. Devicor's acquisition of the vacuum-assisted breast biopsy device maker, for undisclosed terms, includes the flagship Mammotome breast biopsy system (1"The Gray Sheet" April 5, 2010)